Beijing Kawin Technology Share-holding Co Ltd
SSE:688687
Beijing Kawin Technology Share-holding Co Ltd
SSE:688687
Price:
28.21 CNY
-1.12%
Market Closed
Updated:
May 28, 2024
P/E
Price to Earnings
Price to Earnings
40.2
Current
30.6
Median
26.3
Industry
Higher
than median
Higher
than industry value
Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.
P/E
=40.2
Market Cap
/
4.7B
Net Income
117.5m
All Countries
| Market Cap | P/E | ||||
|---|---|---|---|---|---|
| CN |
|
Beijing Kawin Technology Share-holding Co Ltd
SSE:688687
|
4.7B CNY | 40.2 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
271.9B USD | 45.7 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
160.5B USD | 42.6 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
115.4B USD | 28.7 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
106.7B USD | 27.6 | |
| AU |
|
CSL Ltd
ASX:CSL
|
135.6B AUD | 36.5 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
79.7B USD | 164.7 | |
| US |
|
Moderna Inc
NASDAQ:MRNA
|
57.7B USD | -9.7 | |
| US |
|
Seagen Inc
NASDAQ:SGEN
|
43.1B USD | -57.5 | |
| US |
|
Biogen Inc
NASDAQ:BIIB
|
31.6B USD | 27.1 | |
| KR |
|
Celltrion Inc
KRX:068270
|
37.5T KRW | 95.4 |
P/E Forward Multiples
Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/E
30
2-Years Forward
P/E
22.5
3-Years Forward
P/E
17.5
You don't have any saved screeners yet
